Ratings by BMO Capital (Kostas Biliouris)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/23/2025 | CRISPR Therapeutics | CRSP | Maintain | Outperform (N/A) |
|
Details | ||
| 9/22/2025 | Sarepta Therapeutics | SRPT | Upgrade | Outperform (Market Perform) |
17.43 (16.24) |
-6.83% | Details | |
| 9/17/2025 | Korro Bio Inc. | KRRO | Maintain | Outperform (N/A) |
|
Details | ||
| 9/16/2025 | Sarepta Therapeutics | SRPT | Maintain | Market Perform (N/A) |
|
Details | ||
| 9/15/2025 | Tourmaline Bio | TRML | Downgrade | Market Perform (Outperform) |
47.60 (47.98) |
0.8% | Details | |
| 9/8/2025 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 9/5/2025 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 9/3/2025 | Ionis Pharmaceuticals | IONS | Upgrade | Outperform (Market Perform) |
57.49 (73.82) |
28.4% | Details | |
| 8/21/2025 | Ionis Pharmaceuticals | IONS | Maintain | Market Perform (N/A) |
|
Details | ||
| 8/7/2025 | Sarepta Therapeutics | SRPT | Maintain | Market Perform (N/A) |
|
Details | ||
| 8/1/2025 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 7/29/2025 | Sarepta Therapeutics | SRPT | Maintain | Market Perform (N/A) |
|
Details | ||
| 7/22/2025 | Sarepta Therapeutics | SRPT | Maintain | Market Perform (N/A) |
|
Details | ||
| 7/21/2025 | Sarepta Therapeutics | SRPT | Maintain | Market Perform (N/A) |
|
Details | ||
| 7/18/2025 | Sarepta Therapeutics | SRPT | Maintain | Market Perform (N/A) |
|
Details | ||
| 7/7/2025 | Jasper Therapeutics | JSPR | Downgrade | Market Perform (Outperform) |
6.77 (0.53) |
-92.17% | Details | |
| 6/27/2025 | Verve Therapeutics | VERV | Downgrade | Market Perform (Outperform) |
11.21 (11.13) |
-0.71% | Details | |
| 6/24/2025 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 6/17/2025 | Verve Therapeutics | VERV | Maintain | Outperform (N/A) |
|
Details | ||
| 6/16/2025 | Sarepta Therapeutics | SRPT | Maintain | Market Perform (N/A) |
|
Details | ||
| 6/16/2025 | Sarepta Therapeutics | SRPT | Downgrade | Market Perform (Outperform) |
37.31 (17.43) |
-53.28% | Details | |
| 6/5/2025 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 6/4/2025 | BridgeBio Pharma | BBIO | Maintain | Market Perform (N/A) |
|
Details | ||
| 6/2/2025 | Legend Biotech Corp. | LEGN | Maintain | Outperform (N/A) |
|
Details | ||
| 5/27/2025 | Rocket Pharmaceuticals | RCKT | Maintain | Outperform (N/A) |
|
Details | ||
| 5/21/2025 | Tourmaline Bio | TRML | Maintain | Outperform (N/A) |
|
Details | ||
| 5/7/2025 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 4/23/2025 | Verve Therapeutics | VERV | Maintain | (N/A) |
|
Details | ||
| 4/23/2025 | Tourmaline Bio | TRML | Maintain | (N/A) |
|
Details | ||
| 4/23/2025 | Sarepta Therapeutics | SRPT | Maintain | (N/A) |
|
Details | ||
| 4/23/2025 | Silence Therapeutics | SLN | Maintain | (N/A) |
|
Details | ||
| 4/23/2025 | Rocket Pharmaceuticals | RCKT | Maintain | (N/A) |
|
Details | ||
| 4/23/2025 | Prime Medicine | PRME | Maintain | (N/A) |
|
Details | ||
| 4/23/2025 | Intellia Therapeutics | NTLA | Maintain | (N/A) |
|
Details | ||
| 4/23/2025 | Metagenomi Inc | MGX | Maintain | (N/A) |
|
Details | ||
| 4/23/2025 | Korro Bio Inc. | KRRO | Maintain | (N/A) |
|
Details | ||
| 4/23/2025 | Ionis Pharmaceuticals | IONS | Maintain | (N/A) |
|
Details | ||
| 4/23/2025 | Jasper Therapeutics | JSPR | Maintain | (N/A) |
|
Details | ||
| 4/23/2025 | 4D Molecular Therapeutics | FDMT | Maintain | (N/A) |
|
Details | ||
| 4/23/2025 | Precision BioSciences Inc. | DTIL | Maintain | (N/A) |
|
Details | ||
| 4/23/2025 | CRISPR Therapeutics | CRSP | Maintain | (N/A) |
|
Details | ||
| 4/23/2025 | Beam Therapeutics Inc | BEAM | Maintain | (N/A) |
|
Details | ||
| 4/15/2025 | Verve Therapeutics | VERV | Maintain | Outperform (N/A) |
|
Details | ||
| 4/8/2025 | Rocket Pharmaceuticals | RCKT | Maintain | Outperform (N/A) |
|
Details | ||
| 3/26/2025 | Dyne Therapeutics | DYN | Maintain | Outperform (N/A) |
|
Details | ||
| 3/25/2025 | Verve Therapeutics | VERV | Maintain | Outperform (N/A) |
|
Details | ||
| 3/25/2025 | Centessa Pharmaceuticals | CNTA | Maintain | Outperform (N/A) |
|
Details | ||
| 3/12/2025 | Legend Biotech Corp. | LEGN | Maintain | Outperform (N/A) |
|
Details | ||
| 3/12/2025 | Avidity Biosciences | RNA | New Coverage | Outperform (N/A) |
30.04 (12.17) |
-59.49% | Details | |
| 3/12/2025 | Dyne Therapeutics | DYN | New Coverage | Outperform (N/A) |
11.50 (17.99) |
56.43% | Details | |
| 3/12/2025 | Rocket Pharmaceuticals | RCKT | New Coverage | Outperform (N/A) |
8.59 (2.92) |
-66.01% | Details | |
| 3/4/2025 | Silence Therapeutics | SLN | Maintain | Outperform (N/A) |
|
Details | ||
| 2/20/2025 | Ionis Pharmaceuticals | IONS | Maintain | Market Perform (N/A) |
|
Details | ||
| 2/20/2025 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Outperform (N/A) |
|
Details | ||
| 2/11/2025 | Beam Therapeutics Inc | BEAM | Maintain | Outperform (N/A) |
|
Details | ||
| 1/28/2025 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 1/13/2025 | 4D Molecular Therapeutics | FDMT | Downgrade | Market Perform (Outperform) |
5.84 (9.53) |
63.18% | Details | |
| 1/10/2025 | Intellia Therapeutics | NTLA | Maintain | Outperform (N/A) |
|
Details | ||
| 1/10/2025 | Precision BioSciences Inc. | DTIL | Upgrade | Outperform (Market Perform) |
4.79 (6.04) |
26.1% | Details | |
| 1/8/2025 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 12/9/2024 | Beam Therapeutics Inc | BEAM | Maintain | Outperform (N/A) |
|
Details | ||
| 12/2/2024 | Sarepta Therapeutics | SRPT | Maintain | Outperform (Outperform) |
|
Details | ||
| 12/2/2024 | Silence Therapeutics | SLN | Maintain | Outperform (Outperform) |
|
Details | ||
| 11/25/2024 | BridgeBio Pharma | BBIO | Maintain | Market Perform (N/A) |
|
Details | ||
| 11/25/2024 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 11/19/2024 | Silence Therapeutics | SLN | Maintain | Outperform (N/A) |
|
Details | ||
| 11/4/2024 | Precision BioSciences Inc. | DTIL | Maintain | Market Perform (N/A) |
|
Details | ||
| 10/25/2024 | Prime Medicine | PRME | Maintain | Outperform (Outperform) |
|
Details | ||
| 10/24/2024 | Intellia Therapeutics | NTLA | Maintain | Outperform (N/A) |
|
Details | ||
| 10/16/2024 | Korro Bio Inc. | KRRO | Maintain | Outperform (N/A) |
|
Details | ||
| 10/16/2024 | Intellia Therapeutics | NTLA | Maintain | Outperform (N/A) |
|
Details | ||
| 10/16/2024 | Legend Biotech Corp. | LEGN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/10/2024 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 10/9/2024 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 10/9/2024 | Legend Biotech Corp. | LEGN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/4/2024 | Prime Medicine | PRME | Maintain | Outperform (N/A) |
|
Details | ||
| 10/1/2024 | Prime Medicine | PRME | Maintain | Outperform (N/A) |
|
Details | ||
| 9/30/2024 | Legend Biotech Corp. | LEGN | Maintain | Outperform (N/A) |
|
Details | ||
| 9/30/2024 | BridgeBio Pharma | BBIO | Maintain | Market Perform (N/A) |
|
Details | ||
| 9/27/2024 | Centessa Pharmaceuticals | CNTA | Maintain | Outperform (N/A) |
|
Details | ||
| 9/24/2024 | BridgeBio Pharma | BBIO | Maintain | Market Perform (N/A) |
|
Details | ||
| 9/19/2024 | 4D Molecular Therapeutics | FDMT | Maintain | Outperform (N/A) |
|
Details | ||
| 9/17/2024 | Korro Bio Inc. | KRRO | Maintain | Outperform (N/A) |
|
Details | ||
| 9/17/2024 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Outperform (Outperform) |
|
Details | ||
| 9/11/2024 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 9/10/2024 | Centessa Pharmaceuticals | CNTA | Maintain | Outperform (Outperform) |
|
Details | ||
| 9/9/2024 | Centessa Pharmaceuticals | CNTA | Maintain | Outperform (N/A) |
|
Details | ||
| 9/6/2024 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Outperform (N/A) |
|
Details | ||
| 8/30/2024 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (Outperform) |
|
Details | ||
| 8/27/2024 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 8/16/2024 | Silence Therapeutics | SLN | Maintain | Outperform (N/A) |
|
Details | ||
| 8/15/2024 | Korro Bio Inc. | KRRO | Maintain | Outperform (N/A) |
|
Details | ||
| 8/14/2024 | Centessa Pharmaceuticals | CNTA | Maintain | Outperform (N/A) |
|
Details | ||
| 8/13/2024 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 8/12/2024 | Legend Biotech Corp. | LEGN | Maintain | Outperform (N/A) |
|
Details | ||
| 8/12/2024 | 4D Molecular Therapeutics | FDMT | Maintain | Outperform (N/A) |
|
Details | ||
| 8/2/2024 | Ionis Pharmaceuticals | IONS | Downgrade | Market Perform (Outperform) |
49.46 (57.49) |
16.24% | Details | |
| 7/23/2024 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 7/18/2024 | 4D Molecular Therapeutics | FDMT | Maintain | Outperform (N/A) |
|
Details | ||
| 7/16/2024 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (Outperform) |
|
Details | ||
| 7/2/2024 | Legend Biotech Corp. | LEGN | Maintain | Outperform (N/A) |
|
Details | ||
| 6/27/2024 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 6/26/2024 | Intellia Therapeutics | NTLA | Maintain | Outperform (N/A) |
|
Details | ||
| 6/24/2024 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 6/18/2024 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 6/17/2024 | Silence Therapeutics | SLN | Maintain | Outperform (N/A) |
|
Details | ||
| 6/13/2024 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 6/10/2024 | 4D Molecular Therapeutics | FDMT | Maintain | Outperform (N/A) |
|
Details | ||
| 6/7/2024 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 6/7/2024 | 4D Molecular Therapeutics | FDMT | Maintain | Outperform (N/A) |
|
Details | ||
| 6/5/2024 | BridgeBio Pharma | BBIO | Maintain | Outperform (N/A) |
|
Details | ||
| 6/3/2024 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 5/29/2024 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 5/28/2024 | Silence Therapeutics | SLN | Maintain | Outperform (N/A) |
|
Details | ||
| 5/22/2024 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 5/21/2024 | Korro Bio Inc. | KRRO | Maintain | Outperform (N/A) |
|
Details | ||
| 5/17/2024 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 5/15/2024 | Korro Bio Inc. | KRRO | Maintain | Outperform (N/A) |
|
Details | ||
| 5/10/2024 | Intellia Therapeutics | NTLA | Maintain | Outperform (N/A) |
|
Details | ||
| 4/23/2024 | Beam Therapeutics Inc | BEAM | Maintain | Outperform (N/A) |
|
Details | ||
| 4/17/2024 | Legend Biotech Corp. | LEGN | Maintain | Outperform (N/A) |
|
Details | ||
| 4/8/2024 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 4/3/2024 | Verve Therapeutics | VERV | Maintain | Outperform (N/A) |
|
Details | ||
| 4/1/2024 | 4D Molecular Therapeutics | FDMT | Maintain | Outperform (N/A) |
|
Details | ||
| 3/28/2024 | 4D Molecular Therapeutics | FDMT | Maintain | Outperform (N/A) |
|
Details | ||
| 3/14/2024 | Legend Biotech Corp. | LEGN | Maintain | Outperform (N/A) |
|
Details | ||
| 3/13/2024 | Silence Therapeutics | SLN | Maintain | Outperform (Outperform) |
|
Details | ||
| 3/5/2024 | Metagenomi Inc | MGX | New Coverage | Outperform (N/A) |
12.00 (1.33) |
-88.92% | Details | |
| 2/27/2024 | Korro Bio Inc. | KRRO | New Coverage | Outperform (N/A) |
49.99 (11.08) |
-77.84% | Details | |
| 2/13/2024 | Silence Therapeutics | SLN | Maintain | Outperform (N/A) |
|
Details | ||
| 2/5/2024 | 4D Molecular Therapeutics | FDMT | Maintain | Outperform (N/A) |
|
Details | ||
| 1/31/2024 | BridgeBio Pharma | BBIO | New Coverage | Market Perform (N/A) |
37.84 (65.48) |
73.04% | Details | |
| 1/31/2024 | Sarepta Therapeutics | SRPT | New Coverage | Outperform (N/A) |
120.50 (37.31) |
-69.04% | Details | |
| 1/31/2024 | Silence Therapeutics | SLN | New Coverage | Outperform (N/A) |
18.90 (6.41) |
-66.08% | Details | |
| 11/10/2023 | Intellia Therapeutics | NTLA | Maintain | Outperform (N/A) |
|
Details | ||
| 11/8/2023 | Precision BioSciences Inc. | DTIL | Maintain | Market Perform (N/A) |
|
Details | ||
| 11/2/2023 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/10/2023 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 10/9/2023 | Prime Medicine | PRME | New Coverage | Outperform (N/A) |
8.88 (3.14) |
-64.64% | Details | |
| 7/25/2023 | Centessa Pharmaceuticals | CNTA | Maintain | Outperform (N/A) |
|
Details | ||
| 7/5/2023 | BioMarin Pharmaceutical Inc. | BMRN | Upgrade | Outperform (Market Perform) |
86.68 (54.66) |
-36.94% | Details | |
| 5/8/2023 | Intellia Therapeutics | NTLA | Maintain | Outperform (N/A) |
|
Details | ||
| 5/5/2023 | Intellia Therapeutics | NTLA | Downgrade | Market Perform (Outperform) |
38.58 (13.02) |
-66.25% | Details | |
| 5/5/2023 | Alnylam Pharmaceuticals | ALNY | Upgrade | Outperform (Market Perform) |
199.50 (292.58) |
46.66% | Details | |
| 3/14/2023 | Precision BioSciences Inc. | DTIL | Downgrade | Market Perform (Outperform) |
0.91 (6.04) |
563.74% | Details | |
| 3/14/2023 | Intellia Therapeutics | NTLA | Upgrade | Outperform (Market Perform) |
35.82 (13.02) |
-63.65% | Details | |
| 3/7/2023 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Market Perform (N/A) |
|
Details | ||
| 1/30/2023 | BioMarin Pharmaceutical Inc. | BMRN | New Coverage | Market Perform (N/A) |
116.98 (54.66) |
-53.27% | Details | |
| 1/30/2023 | 4D Molecular Therapeutics | FDMT | New Coverage | Outperform (N/A) |
20.23 (5.84) |
-71.13% | Details | |
| 1/6/2023 | Graphite Bio Inc | GRPH | Downgrade | Market Perform (Outperform) |
3.17 (3.18) |
0.32% | Details | |
| 12/20/2022 | Beam Therapeutics Inc | BEAM | Upgrade | Outperform (Market Perform) |
42.54 (29.55) |
-30.54% | Details | |
| 7/18/2022 | Verve Therapeutics | VERV | Maintain | Outperform (N/A) |
|
Details | ||
| 7/18/2022 | Beam Therapeutics Inc | BEAM | Maintain | Market Perform (N/A) |
|
Details | ||
| 7/8/2022 | Legand Biotech Corp. | LEGN | Maintain | Outperform (N/A) |
|
Details | ||
| 6/17/2022 | Beam Therapeutics Inc | BEAM | New Coverage | Market Perform (N/A) |
31.95 (29.55) |
-7.51% | Details | |
| 6/17/2022 | Intellia Therapeutics | NTLA | New Coverage | Market Perform (N/A) |
40.93 (13.02) |
-68.19% | Details | |
| 6/17/2022 | Precision BioSciences Inc. | DTIL | New Coverage | Outperform (N/A) |
1.21 (6.04) |
399.17% | Details | |
| 6/17/2022 | Graphite Bio Inc | GRPH | New Coverage | Outperform (N/A) |
2.33 (3.18) |
36.48% | Details | |
| 6/17/2022 | CRISPR Therapeutics | CRSP | New Coverage | Outperform (N/A) |
62.66 (52.08) |
-16.88% | Details | |
| 6/17/2022 | Centessa Pharmaceuticals | CNTA | New Coverage | Outperform (N/A) |
4.26 (39.85) |
835.45% | Details | |
| 6/17/2022 | Legand Biotech Corp. | LEGN | New Coverage | Outperform (N/A) |
43.56 (35.98) |
-17.4% | Details | |
| 6/17/2022 | Verve Therapeutics | VERV | New Coverage | Outperform (N/A) |
12.29 (11.21) |
-8.79% | Details |
